As of now, Marianne De Backer owns 456,357 shares of common stock in Vir Biotechnology, which is currently valued at approximately $11.5 million. Her stockholding reflects her confidence in the company's future and aligns her interests with that of the...

As of now, Marianne De Backer owns 456,357 shares of common stock in Vir Biotechnology, which is currently valued at approximately $11.5 million. Her stockholding reflects her confidence in the company's future and aligns her interests with that of the shareholders. Notably, she received a substantial equity award during her appointment, totaling over 1.7 million shares in stock options and restricted stock units, which will vest over the next few years. The value of these holdings and options can fluctuate based on company performance and market conditions. With an initial stock grant at her CEO appointment and her ongoing investment, her financial future is tied closely to the success of Vir Biotechnology, highlighting a strong alignment with shareholder interests.